Well, I’m coming at this one from a different angle, I’m not...

Well, I’m coming at this one from a different angle, I’m not carrying any baggage, being a post-debacle investor.
Let the CR wash through, the company is then financed to production, and the options money, plus loan funding opportunities, should flow, it’s conceivable that they may not need another CR, but even if they do, it shouldn’t be huge.
Regarding the alkaline/acid argument, the company has made it clear that, so far as their project is concerned, the decision they’ve taken is solidly based on empirical evidence, that’s the only thing that counts.
Relax, sit back and let it happen. IMO, the potential here is multiples of the current sp.
Let’s see - not long to wait.
Oh! By the way - there is plenty of interest in this one, just look at the recent market action.
B22.